Medicure Announces CFO Change
WINNIPEG, MB / ACCESS Newswire / July 3, 2026 / Medicure Inc. ("Medicure" or the "Company") (TSXV:MPH)(OTC PINK:MCUJF), a company...
Clinical Trial
Xtalks Announces its Life Science Webinar Calendar for July 2026
Upcoming free, educational webinars from Xtalks will feature topics on biomarkers, clinical trials, commercialization and HEOR, emerging market, food ingredients...
DoH and MIT- Koch Institute Partner to Advance AI-Driven Cancer Research
ABU DHABI, UAE, July 3, 2026 /PRNewswire/ -- The Department of Health – Abu Dhabi (DoH), the regulator of the...
Greenlight Guru achieves ISO 42001 certification for AI governance across medtech quality and clinical solutions
The certification covers AI governance across the company's eQMS and EDC products, giving medical device companies independently verified evidence for...
ASCO 2026: Turn Oncology Data into Smarter Trial Strategy, Upcoming Webinar Hosted by Xtalks
In this free webinar, oncology experts will discuss what ASCO 2026 data could mean for cancer clinical trials and patient...
Oculis to Participate at the Piper Sandler Virtual Ophthalmology Conference
ZUG, Switzerland, July 2, 2026 – Oculis Holding AG (Nasdaq: OCS; XICE: OCS) (“Oculis” or the “Company”), a global biopharmaceutical...
Oculis to Participate at the Piper Sandler Virtual Ophthalmology Conference
ZUG, Switzerland, July 02, 2026 (GLOBE NEWSWIRE) -- Oculis Holding AG (Nasdaq: OCS; XICE: OCS) (“Oculis” or the “Company”), a...
Abivax Announces Full Exercise of Underwriters’ Option to Purchase Additional ADSs, Bringing Gross Proceeds of Offering to $920M (€807M)
Abivax Announces Full Exercise of Underwriters’ Option to Purchase Additional ADSs, Bringing Gross Proceeds of Offering to $920M (€807M) PARIS,...
Novartis receives European Commission approval for Itvisma® for spinal muscular atrophy (SMA)
First gene replacement therapy in the EU for broad population with SMA, including children two years and older, teens and...
Elicio Therapeutics Announces Pricing of $15 Million Registered Direct Offering
BOSTON, July 02, 2026 (GLOBE NEWSWIRE) -- Elicio Therapeutics, Inc. (Nasdaq: ELTX) (“Elicio” or the “Company”), a clinical-stage biotechnology company...
FDA Alignment to Advance ProstACT Global Phase 3 Trial
FDA and Telix align on advancement into Part 2 of the ProstACT Global Phase 3 study in the United States.FDA...
Junshi Biosciences Enters Licensing Collaboration with Fosun Wanbang on Roconkibart (IL-17A)
SHANGHAI, July 01, 2026 (GLOBE NEWSWIRE) -- Shanghai Junshi Biosciences Co., Ltd (Junshi Biosciences, HKEX: 1877; SSE: 688180), a leading...
FDA Approves First Gene Therapy for Young Children with Sickle Cell Disease
State-of-the-art gene therapy provides new treatment option for children 2 years and older with life-threatening blood disorderSilver Spring, MD, July...
Candel Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
NEEDHAM, Mass., July 01, 2026 (GLOBE NEWSWIRE) -- Candel Therapeutics, Inc. (Candel or the Company) (Nasdaq: CADL), a clinical-stage biopharmaceutical...
Covenant Makes Follow-On Investment in Hill Research, Citing Fourfold Revenue Growth and Accelerating Market Adoption
Covenant's second commitment to Hill Research signals sustained conviction in a high-growth portfolio company operating at the intersection of artificial...
Covenant Makes Follow-On Investment in Hill Research, Citing Fourfold Revenue Growth and Accelerating Market Adoption
Covenant's second commitment to Hill Research signals sustained conviction in a high-growth portfolio company operating at the intersection of artificial...
BIOSAPIEN – THE REVOLUTIONARY CANCER PLATFORM DEVELOPER – ANNOUNCES TWO, WORLD-CLASS US MANUFACTURING PARTNERS: ROSWELL PARK AND BA SCIENCES
SAN DIEGO, July 1, 2026 /PRNewswire/ -- BioSapien, the pioneering biotech company, announces two world-class US manufacturing partners, ahead of...
BIOSAPIEN – THE REVOLUTIONARY CANCER PLATFORM DEVELOPER – ANNOUNCES TWO, WORLD-CLASS US MANUFACTURING PARTNERS: ROSWELL PARK AND BA SCIENCES
SAN DIEGO, July 1, 2026 /PRNewswire/ -- BioSapien, the pioneering biotech company, announces two world-class US manufacturing partners, ahead of...
Stemtech Corporation Declares July 2026 “Cellular Health Awareness Month”
Spotlighting Two Decades of Natural Regenerative Support, Anti-Aging and Longevity Science, AI-Recognized Pioneer-Leader in Stem Cell Nutrition Marks 20 Years...
Remepy Publishes New Evidence Showing its Hybrid Drug, Hybridopa™, Effect on Structural Connectivity in the Brain of Parkinson’s Patients Associated with Improved Clinical Outcome
New npj Parkinson's Disease publication, building on the previously reported Hybridopa™ Phase IIa results, demonstrates for the first time, that...